Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis

Expert Opinion on Biological Therapy

Volumn 16, Issue 4, 2016, Pages 507-514

  Brar, Kanwaljit ^a   Leung, Donald Y M ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Atopic dermatitis; Biological; Eczema herpeticum; Interferon gamma; Skin infection

Indexed keywords

GAMMA INTERFERON; RECOMBINANT GAMMA INTERFERON; RECOMBINANT PROTEIN;

ATOPIC DERMATITIS; BIOLOGICAL THERAPY; DRUG USE; ENDOPHENOTYPE; EOSINOPENIA; FLU LIKE SYNDROME; GENETIC VARIABILITY; HUMAN; HYPERTRANSAMINASEMIA; KAPOSI VARICELLIFORM ERUPTION; KERATINOCYTE; NEUTROPENIA; REVIEW; SPLENOMEGALY; STAPHYLOCOCCUS INFECTION; DERMATITIS, ATOPIC; IMMUNOLOGY; TH1 CELL;

BIOLOGICAL THERAPY; DERMATITIS, ATOPIC; HUMANS; INTERFERON-GAMMA; RECOMBINANT PROTEINS; TH1 CELLS;

EID: 84962159304     PISSN: 14712598     EISSN: 17447682     Source Type: Journal    
DOI: 10.1517/14712598.2016.1135898     Document Type: Review

References (44)

1. Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014;134:769-779 DOI:10. 1016/j. jaci. 2014. 08. 008.
2. Leung DYM. Atopic dermatitis: age and race do matter! J Allergy Clin Immunol. 2015;136:1265-1267. DOI:10. 1016/ j. jaci. 2015. 09. 011.
3. Gao PS, Rafaels NM, Hand T, et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. J Allergy Clin Immunol. 2009;124:507-513. DOI:10. 1016/j. jaci. 2009. 07. 034.
4. Cai SC, Chen H, Koh WP, et al. Filaggrin mutations are associated with recurrent skin infection in Singaporean Chinese patients with atopic dermatitis. Br J Dermatol. 2012;166:200-203. DOI:10. 1111/j. 1365-2133. 2011. 10541. x.
5. Van Drongelen V, Haisma EM, Out-Luiting JJ, et al. Reduced filaggrin expression is accompanied by increased Staphylococcus aureus colonization of epidermal skin models. Clin Exp Allergy. 2014;44(12):1515-1524. DOI:10. 1111/cea. 12443.
6. Brauweiler AM, Bin L, Kim BE, et al. Filaggrin-dependent secretion of sphingomyelinase protects against staphylococcal-toxin-induced keratinocyte death. J Allergy Clin Immunol. 2013;131(2):421-422. DOI:10. 1016/j. jaci. 2012. 10. 030.
7. Beck LA, Thaçi D, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371:130-139. DOI:10. 1056/NEJMoa1314768.
8. Hamilton JD, Suárez-Fariñas M, Dhingra N, et al. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis. J Allergy Clin Immunol. 2014;134:1293-1300. DOI:10. 1016/j. jaci. 2014. 10. 013.
9. Farrar MA, Schreiber RD. The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol. 1993;11:571-611. DOI:10. 1146/annurev. iy. 11. 040193. 003035
10. The International Chronic Granulomatous Disease Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic gramulomatous disease. N Engl J Med. 1991;324:509-516. DOI:10. 1056/ NEJM199102213240801.
11. Marciano BE, Wesley R, De Carlo ES, et al. Long-term interferon-therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39:692-699. DOI:10. 1086/422993.
12. Leung DY, Gao PS, Grigoryev DN, et al. Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-gamma response. J Allergy Clin Immunol. 2011;127:965-973. DOI:10. 1016/j. jaci. 2011. 02. 010.
13. Machura E, Mazur B, Golemiec E, et al. Staphylococcus aureus skin colonization in atopic dermatitis children is associated with decreased IFN-gamma production by peripheral blood CD4+ and CD8+ T cells. Pediatr Allergy Immunol. 2008;19:37-45. DOI:10. 1111/j. 1399-3038. 2007. 00586. x.
14. Leyva-Castillo JM, et al. TSLP produced by keratinocytes promotes allergen sensitization through skin and thereby triggers atopic march in mice. J Invest Dermatol. 2013;133:154-163. DOI:10. 1038/jid. 2012. 239.
15. Van Der Velden VH, Laan MP, Baert MR, et al. Selective development of a strong Th2 cytokine profile in high-risk children who develop atopy: risk factors and regulatory role of IFN-gamma, IL-4 and IL-10. Clin Exp Allergy. 2001;31:997-1006.
16. Herberth G, Heinrich J, Roder S, et al. Reduced IFN-gammaand enhanced IL-4-producing CD41 cord blood T cells are associated with a higher risk for atopic dermatitis during the first 2 years of life. Pediatr Allergy Immunol. 2010;21:5-13 DOI:10. 1111/j. 1399-3038. 2009. 00890. x.
17. Warner JA, Miles EA, Jones AC, et al. Is deficiency of interferon gamma production by allergen triggered cord blood cells a predictor of atopic eczema Clin Exp Allergy. 1994;24:423-430.
18. Akkoc T, De Koning PJ, Rückert B, et al. Increased activation-induced cell death of high IFN-producing TH1 cells as a mechanism of TH2 predominance in atopic diseases. J Allergy Clin Immunol. 2008;121:652-658. DOI:10. 1016/j. jaci. 2007. 12. 1171.
19. Czarnowicki T, Gonzalez J, Shemer A, et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol. 2015;136:104-115. DOI:10. 1016/j. jaci. 2015. 01. 020
20. Park H, Ahn K, Park MH, et al. The HLA-DRB1 polymorphism is associated with atopic dermatitis, but not egg allergy in Korean children. Allergy Asthma Immunol Res. 2012;4:143-149. DOI:10. 4168/aair. 2012. 4. 3. 143.
21. Giustizieri ML, Mascia F, Frezzolini A, et al. Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines. J Allergy Clin Immunol. 2001;107:871-877. DOI:10. 1067/mai. 2001. 114707.
22. Mathes EF, Oza V, Frieden IJ, et al. "Eczema coxsackium" and unusual cutaneous findings in an enterovirus outbreak. Pediatrics. 2013;132:e149-157. DOI:10. 1542/ peds. 2012-3175.
23. Seize MB, Ianhez M, Cestari SC. A study of the correlation between molluscum contagiosum and atopic dermatitis in children. An Bras Dermatol. 2011;86:663-668.
24. Feder HM Jr, Bennett N, Modlin JF. Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6. Lancet Infect Dis. 2014;14:83-86. DOI:10. 1016/S1473-3099(13)70264-0.
25. Nahmias AJ, Froeschle JE, Feorino PM, et al. Generalized eruption in a child with eczema due to coxsackievirus A16. Arch Dermatol. 1968;97:147-148.
26. Harris PN, Wang AD, Yin M, et al. Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. Lancet Infect Dis. 2014;14:1043. DOI:10. 1016/ S1473-3099(14)70940-5.
27. Gao P-S, Rafaels NM, Mu D, et al. Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol. 2010;125:1403-1407. DOI:10. 1016/j. jaci. 2010. 03. 016.
28. Gao P-S, Leung DY, Rafaels NM, et al. Genetic variants in interferon regulatory factor 2 (IRF2) are associated with atopic dermatitis and eczema herpeticum. J Invest Dermatol. 2012;132:650-657. DOI:10. 1038/jid. 2011. 374.
29. Bin L, Edwards MG, Heiser R, et al. Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol. 2014;134:848-855. DOI:10. 1016/j. jaci. 2014. 07. 018.
30. Dorman SE, Uzel G, Roesler J, et al. Viral infections in interferon-gamma receptor deficiency. J Pediatr. 1999;135:640-643.
31. Gao L, Bin L, Rafaels NM, et al. Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol. 2015;136:1591-1600. DOI:10. 1016/j. jaci. 2015. 06. 047.
32. Boguniewicz M, Jaffe HS, Izu A, et al. Recombinant gamma interferon in treatment of patients with atopic dermatitis and elevated IgE levels. Am J Med. 1990;88:365-370.
33. Hanifin JM, Schneider LC, Leung DY, et al. Recombinant interferon gamma therapy for atopic dermatitis. J Am Acad Dermatol. 1993;28:189-197.
34. Jang IG, Yang JK, Lee HJ, et al. Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma. J Am Acad Dermatol. 2000;42:1033-1040.
35. Reinhold U, Kukel S, Brzoska J, et al. Systemic interferon gamma treatment in severe atopic dermatitis. J Am Acad Dermatol. 1993;29:58-63.
36. Ellis CN, Stevens SR, Blok BK, et al. Interferon-therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement. Clin Immunol. 1999;92:49-55. DOI:10. 1006/clim. 1999. 4731.
37. Stevens SR, Hanifin JM, Hamilton T, et al. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol. 1998;134:799-804.
38. Schneider LC, Baz Z, Zarcone C, et al. Long-term therapy with recombinant interferon-gamma (rIFN-) for atopic dermatitis. Ann Allergy Asthma Immunol. 1998;80:263-268 DOI:10. 1016/S1081-1206(10)62968-7.
39. Noda S, Suárez-Fariñas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol. 2015 Sep 28;136:1254-1264. DOI:10. 1016/j. jaci. 2015. 08. 015. Epub ahead of print.
40. Nakajima H, Loegering DA, Kita H, et al. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins. J Leukoc Biol. 1999;66:447-454.
41. Sechler JM, Malech HL, White CJ, et al. Recombinant human interferon-gamma reconstitutes defective phagocyte function in patients with chronic granulomatous disease of childhood. Proc Natl Acad Sci U S A. 1988;85:4874-4878.
42. Ezekowitz RA, Orkin SH, Newburger PE. Recombinant interferon gamma augments phagocyte superoxideproduction and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest. 1987;80:1009-1016. DOI:10. 1172/ JCI113153.
43. Tang ML, Kemp AS, Thorburn J, et al. Reduced interferongamma secretion in neonates and subsequent atopy. Lancet. 1994;344:983-985.
44. Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol. 2015;136:1170-1177. DOI:10. 1016/j. jaci. 2015. 08. 028